Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
4.090
+0.170 (4.34%)
May 18, 2026, 4:00 PM EDT - Market closed
Evaxion Employees
Evaxion had 46 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
46
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$163,652
Profits / Employee
-$212,087
Market Cap
34.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 46 | 0 | - |
| Dec 31, 2024 | 46 | -3 | -6.12% |
| Dec 31, 2023 | 49 | -14 | -22.22% |
| Dec 31, 2022 | 63 | 2 | 3.28% |
| Dec 31, 2021 | 61 | 26 | 74.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| NextCure | 40 |
| Senti Biosciences Holdings | 39 |
| Boundless Bio | 28 |
| Daré Bioscience | 24 |
| Veru Inc. | 20 |
| Tevogen Bio Holdings | 18 |
| CervoMed | 15 |
EVAX News
- 6 days ago - Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress - GlobeNewsWire
- 11 days ago - Evaxion Earnings Call Transcript: Q1 2026 - Transcripts
- 11 days ago - Evaxion announces business update and first quarter 2026 financial results - GlobeNewsWire
- 14 days ago - Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026 - GlobeNewsWire
- 21 days ago - Evaxion Biotech management to meet with Maxim - TheFly
- 21 days ago - Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer - GlobeNewsWire
- 4 weeks ago - Evaxion says EVX-01 demonstrates 86% vaccine target precision in trial - TheFly
- 4 weeks ago - Evaxion's AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial - GlobeNewsWire